Otsuka defends validity of injectable Abilify patent, accuses Sun Pharma of infringement

Intellectual Property 2024-05-30 2:19 pm By Sam Matthews Melbourne

Otsuka Pharmaceutical has hit back at suit filed by Indian generics company Sun Pharma seeking to invalidate its patent for blockbuster antipsychotic Abilify, filing a cross-claim seeking to restrain Sun Pharma from infringing the patent with a generic version of the drug.